Impaired learning memory capacity is one of the most significant clinical symptoms of AD, and pathological changes such as Aβ pathology, tau hyperphosphorylation, and inflammation-related indicators can reflect the severity of the disease and are often used as indicators of treatment efficacy. The gene discussed is MAPT; the disease is Alzheimer disease.